Junction
PrivateLast Round
Series A
Mar 11, 2025
Est. Valuation
$90M
Total Funding Raised
$21.05M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Junction operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in March 2025.
Junction is a healthcare infrastructure company that provides a unified API platform for healthcare organizations to integrate lab testing, medical devices, and wearable data.
Sector
Healthcare & Life Sciences
Verticals
Data Integration, Precision Medicine, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Junction Comparables
Compare Junction with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ash | 79% | |
| Zus Health | 78% | |
| Particle Health | 78% |
For institutional investors. Book with your work email.
Junction Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 11, 2025 | ||||
| Seed | Jun 3, 2022 | ||||
| Accelerator | Mar 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Junction Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Point Nine | Series A, Seed |
| 20VC | Seed |
| Gaingels | Seed |
| Creandum | Series A |
| Inflect Health | Seed, Series A |
| Amino Collective | Seed, Series A |
| Y Combinator | Seed, Series A, Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Revenue quadrupled over the past year.
- Apr 9, 2026
Supports scalable access to the Galleri multi-cancer early detection test.
For institutional investors. Book with your work email.
Junction Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Junction's valuation, stock price, and market status.
Is Junction a public or private company?
Junction is a private company.
What is the current stock price of Junction?
Junction is a private company, so its shares have no public market price. Caplight tracks Junction's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Junction worth (valuation)?
Junction's valuation is estimated at $90.0M based on funding round data.
Can I buy Junction stock?
Junction shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Junction's last funding round?
Junction's most recent funding round was Series A on March 11, 2025.
Who are the main investors in Junction?
Key investors in Junction include Point Nine, Creandum, Y Combinator.
Will Junction IPO soon?
No public IPO plans have been announced for Junction.
How can I track Junction secondary market activity?
Caplight tracks bids, offers, and trades in Junction's shares on secondary markets.